Download Genome Editing with engineered nucleases poster

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
GENOME
EDITING
WITH
ENGINEERED NUCLEASES
FOUR FAMILIES
ENGINEERED
MEGA-NUCLEASE
OF DESIGNER RE-ENGINEERED
HOMING
ENDONUCLEASES
ENGINEERED
NUCLEASES
GENOME EDITING
IN WHICH DNA IS
INSERTED, REPLACED, OR REMOVED
USING ARTIFICIALLY
ENGINEERED NUCLEASES,
OR “MOLECULAR SCISSORS”
LEFT TALEN
TRANSCRIPTION
ACTIVATOR-LIKE EFFECTOR
NUCLEASES (TAL EFFECTOR
NUCLEASES)
FOKI
RIGHT TALEN
RIGHT ZFN
FOKI
ZINC FINGER
NUCLEASES (ZFNS)
CAS9 PROTEIN
CRISPR-CAS SYSTEM
(CLUSTERED REGULARLY
INTERSPACED SHORT
PALINDROMIC REPEATS)
GUIDE
RNA
LEFT ZFN
NUCLEASE-MEDIATED
GENOME EDITING
CHROMOSOME &
ENGINEERED NUCLEASE
GENE
DISRUPTION
GENE
INSERTION
GENE
DELETION
INVERSION
SPECIES
DNA-SPECIFIC
DOUBLE-STRANDED BREAK
GENE
GENE
ADDITION CORRECTION
APPLIED IN A DIVERSE
SET OF SPECIES
Human cell lines
& stem cells
Drosophila, insects
C. elegans
Zebrafish
Mice, rats
Pigs
Cows
Plants
Monkeys
HOMOLOGY-DIRECTED REPAIR (HR)
With added homologous DNA:
insert/replace DNA
NON-HOMOLOGOUS END JOINING (NHEJ)
Without added homologous DNA:
repairs with indels
THERE ARE OVER
21,000 PUBLICATIONS
IN THE GENOME EDITING SPACE
# of publications
PUBLICATIONS
≥3,000
≥2,500
≥2,000
≥1,500
≥1,000
≥500
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
0
ENTRY OF ZFN
ENTRY OF
TAL EFFECTOR
POTENTIAL AND THE FUTURE
STEM CELL
ENGINEERING
& GENE THERAPY
DISEASE-RESISTANT
TRANSGENIC
PLANTS
Request a copy of this poster for your lab at lifetechnologies.com/genomeeditposters
For Research Use Only. Not for use in diagnostic procedures. © 2014 Thermo Fisher Scientific Inc. All rights reserved.
All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.
TISSUE & ANIMAL
DISEASE MODELS
ENTRY OF
CRISPR
Related documents